Jason Norman

looking forward to #ESCMIDGlobal next week in Vienna. I'd love to connect and discuss developing microbiome drugs to prevent infection. Come to the Innovation Theater 12 April at 11:30!

If you're a scientist at the NIH or another HHS agency who was affected by today's RIF, I'd love to hear about the work you were doing and how important it was for our nation's health! I'm a staff writer at Fierce Biotech, and I can be reached through DM on BlueSky or securely on Signal at dinc.49

Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status - Nature Communications Here, the authors present a global meta-analysis of the human gut bacterium Ruminococcus gnavus, established an isolate collection with complete genomes and identified genetic features correlating wit...

New publication: This is work stems from the mind of Quinten Ducarmon, and was led by PhD student Sam Nooij. Our group contributed to the culturing of the isolates and generating the complete genomes.

What 's in this manuscript? 👇

www.nature.com/articles/s41...

Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today annou

www.businesswire.com/news/home/20...

Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection - Nature Medicine Results of multi-omic profiling of the microbiome and host immunity of individuals treated with VE303 to prevent recurrent Clostridioides difficile infection in the context of a phase 2 trial show rob...

Our team published additional results from the Phase 2 CONSORTIUM study for our rCDI candidate, VE303.
This research offers new insights into PK-PD relationships and the mechanisms of action of VE303, providing a rationale for the drug’s protective effects in rCDI.
www.nature.com/articles/s41...

Reposting from the other place.. I am looking to hire a Bioinformatics Scientist to join the Systems Biology team at Vedanta Biosciences, Inc. We're considering candidates local to Boston and up to 100% remote (if in the US). Please help me spread the word job-boards.greenhouse.io/vedantabiosc...

chalk + chalkboard with diagrams

lab group silly picture

Wow - bluesky! 📈 🦠

Please help me amplify a special faculty search. We're looking for someone in "Microbial Systems Biology" to join me and @kreynoldslab.bsky.social at UTSW Sys Bio / Bioinformatics.

There is an empty lab space right next to us waiting for you!

apply.interfolio.com/154339

1/4

Nice paper by Nishijima et al, from Bork's lab using machine learning to show that the absolute bacterial load is a major confounder in most human microbiome studies (www.cell.com/cell/fulltex.... Now seems a good time to outline the approaches that we have been developing.

I’d love to be added if there’s room

Hello world. I'm a researcher at Vedanta Biosciences where we are developing defined bacterial consortia to modulate the microbiome and treat or prevent human disease. General focus areas: microbial ecology, drug discovery, IBD and infectious disease. Wordcloud via scholargoggler.com

Another lovely feature of this platform to decelerate the dunking/hot takes: if someone has quote-posted you with negative/snarky commentary, you can detach your post from their quote. You can also turn quote posts off altogether when composing a new post.

A great opportunity for sure 👇🏻

A thread with some new starter packs in genomics and bioinformatics 🧵 1/13...

@claesengroup.bsky.social made a couple of great #microbiome starter packs

shout out to BioRender users... NIAID created a free version bioart.niaid.nih.gov

Fantastic list! Thank you! Can you add me to the list?

I'm looking to grow my #microbiome research network in the platform. Is there a way to search for starter packs? Any recommendations?

Feeling inspired by the @bsky.app growth. Might just have to get back into the social media groove. Keep posting all things science and drug dev y’all.

really looking forward to #DDW2024 and to share some of the latest research from VedantaBio on the VE303 defined consortium for preventing rCDI. I'd love to connect.